Company news

Lantheus Holdings, Inc. news in 2023

Lantheus Holdings, Inc.'s news releases, calls and decks from 2023, newest first.

View company

Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate Cancer

December 17, 2023

Lantheus Reports Third Quarter 2023 Financial Results

November 1, 2023

Lantheus to Host Third Quarter 2023 Earnings Conference Call and Webcast on November 2, 2023, at 8: 00 a.m. Eastern Time

October 18, 2023

Lantheus Announces Top Rated Oral Presentation Featuring PYLARIFY AI™ at the 2023 European Association of Nuclear Medicine (EANM) Annual Meeting

August 31, 2023

Lantheus to Present at the Wells Fargo Healthcare Conference

August 30, 2023

Lantheus Reports Second Quarter 2023 Financial Results

August 2, 2023

Lantheus Announces Agreement to Sell RELISTOR® Royalties to HealthCare Royalty

August 2, 2023

Lantheus to Host Second Quarter 2023 Earnings Conference Call and Webcast on August 3, 2023, at 8: 00 a.m. Eastern Time

July 19, 2023

Lantheus Announces Presentations Featuring PYLARIFY AI™ at the 2023 Society for Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting

June 11, 2023

Lantheus to Present at the Jefferies Healthcare Conference

May 31, 2023

Lantheus Announces Payment to Contingent Value Rights (CVR) Holders of $99.7 million or $1.15 per CVR

May 22, 2023

Lantheus Reports First Quarter 2023 Financial Results

May 3, 2023

Lantheus and POINT Biopharma Announce FDA Grants Fast Track Designation for ¹⁷⁷Lu-PNT2002 for the Treatment of Metastatic Castration Resistant Prostate Cancer

April 23, 2023

Lantheus and POINT Biopharma Announce FDA Grants Fast Track Designation for 177Lu-PNT2002 for the Treatment of Metastatic Castration Resistant Prostate Cancer

April 23, 2023

Lantheus to Host First Quarter 2023 Earnings Conference Call and Webcast on May 4, 2023, at 8: 00 a.m. Eastern Time

April 19, 2023

POINT Biopharma Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Highlights

March 26, 2023

Lantheus Announces Two Key Executive Promotions

March 16, 2023

Lantheus Reports Fourth Quarter and Full Year 2022 Financial Results

February 22, 2023

Lantheus Presents Data Reinforcing Real-World Clinical Utility of Piflufolastat F 18 PET Scanning in Men with Recurrent Prostate Cancer and Low PSA Levels

February 15, 2023

Lantheus to Host Fourth Quarter and Full Year 2022 Earnings Conference Call and Webcast on February 23, 2023, at 8: 00 a.m. Eastern Time

February 8, 2023

Lantheus to Present Piflufolastat F 18 Data at the 2023 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium

February 7, 2023

Lantheus Announces Acquisition of Cerveau Technologies, Inc., Expanding Imaging Pipeline into Alzheimer’s Disease

February 5, 2023

Lantheus to Present at the J.P. Morgan 2023 Healthcare Conference

January 3, 2023

Calls in 2023

Decks in 2023